BBI Group is consolidating and expanding its UK manufacturing operations onto a single site in Caerphilly in an £8.5m investment, supported by the Welsh Government, that will create and safeguard more than three hundred and sixty jobs in Wales (Welsh Government, 2017). BBI Group, which is currently headquartered in Cardiff, has a number of manufacturing … Continue reading BBI Group and the Welsh Government announce multi-million pound investment

Signum Health, a Caerphilly-based digital referral platform for medical professionals, healthcare providers and the public, has secured a six figure equity co-investment from Finance Wales and four angel investors (MediWales, 2017). As well as Finance Wales, investment comes from William Record, owner of Welsh ICE, investment specialist and CEO of Cognis Capital Myra Tabor, former … Continue reading Signum Health secures six figure investment

Alesi Surgical has secured FDA approval for its Ultravision system (MediWales, 2017). The Ultravision system clears the vapour and particulate matter generated by modern surgical cutting instruments during laparoscopic surgery through the use of electrostatic technology. The technology dramatically and effortlessly improves visibility for surgeons that is otherwise rapidly obscured by surgical smoke. Dr Dominic … Continue reading Alesi Surgical gains FDA approval for Ultravision

Magstim has launched INSIGHT, the first cloud-based electronic health record management solution for TMS practices (Mediwales, 2017). Magstim INSIGHT is a convenient and mobile platform created to securely store patient and TMS treatment information. American TMS providers will be able to share data remotely with co-workers, track patients’ progress and chart their treatment outcomes. It … Continue reading Magstim launches health record management solution

IBA, Royal Philips and Proton Partners International have announced that they will be collaborating to build the first compact proton therapy system in the Middle East (MediWales, 2017). The proton therapy centre will be part of a large existing hospital, the Gulf International Cancer Center. The proton therapy centre will be the first compact proton … Continue reading Proton Partners, IBA and Philips Join Forces in Cancer Care in the Middle East

A study into a new treatment for Sanfilippo disease, a rare and fatal condition which causes progressive dementia in children, is progressing well with results set to be published later this year (University of Manchester, 2017). Sanfilippo disease, also known as Mucopolysaccharidosis (MPS) III, currently has no effective treatment. It affects around one hundred and … Continue reading University of Manchester study testing new treatment for Sanfilippo disease progressing well

University of Manchester biologists have discovered that breast tissues have twenty four hour body clocks, and that several hundred genes are regulated in a daily cycle (University of Manchester, 2017). The discovery by Dr Qing-Jun Meng and Professor Charles Streuli, may offer the first evidence of a link between breast biology, including breast cancer risks, … Continue reading Inbuilt body clocks link breast stiffness to cancer risks

The University of Liverpool is to co-ordinate a new £14m European research project which aims to improve the understanding of adverse drug reactions by using cutting-edge modelling approaches to drug safety (University of Liverpool, 2017). Adverse drug reactions (ADRs) are the unwanted side effects of medication. They can contribute significantly to patient morbidity, mortality and … Continue reading University of Liverpool to coordinate £14m drug safety research project

The University of Manchester has, through its Innovation Company (UMI3), signed a licensing and research agreement with Douglas Pharmaceuticals that could save the lives of millions of women around the world suffering from early stage cervical cancer (University of Manchester, 2017). The deal initially sees New Zealand-based Douglas Pharmaceuticals sponsor research at Manchester University to … Continue reading Research agreement could prevent cervical cancer in millions of women

A British Heart Foundation Cymru funded research team led by Professor Alan Williams will be based at Swansea University Medical School from this month (Swansea University, 2017).‌ Swansea University Medical School will offer the opportunity for Alan Williams and his team to continue their unprecedented research in Wales with £2.3m of investment from BHF, after … Continue reading £2.3m BHF Cymru research hosted by Swansea University Medical School